GSK PLC

GSK
Delayed London Stock Exchange - 11:35:17 2023-02-03 am EST
1439.60 GBX +0.85%
Valuation
Fiscal Period: December 2021 2022
Capitalization1 80 45858 381
Enterprise Value (EV)1 100 29658 381
P/E ratio 18,6x3,93x
Yield 4,98%4,23%
Capitalization / Revenue 2,36x1,99x
EV / Revenue 2,94x1,99x
EV / EBITDA 8,85x5,59x
Enterprise Value (EV) / FCF 22,6x13,9x
FCF Yield 4,42%7,21%
Price to Book 5,34x4,69x
Nbr of stocks (in thousands) 4 006 3834 060 999
Reference price (GBP) 20,114,4
Announcement Date 02/09/202202/01/2023
Previous period Next period
1 GBP in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2021 2022
Net sales1 34 11429 324
EBITDA1 11 33010 449
Operating profit (EBIT)1 8 8068 151
Operating Margin 25,8%27,8%
Pre-Tax Profit (EBT)1 5 4425 628
Net income1 4 38514 956
Net margin 12,9%51,0%
EPS2 1,083,66
Free Cash Flow1 4 4375 224
FCF margin 13,0%17,9%
FCF Conversion 39,2%56,4%
Dividend per Share2 1,000,61
Announcement Date 02/09/202202/01/2023
Previous period Next period
1 GBP in Million
2 GBP
Estimates
Finances - Leverage
Fiscal Period: December 2021 2022
Net Debt1 19 83814 349
Net Cash position1 --
Leverage (Debt / EBITDA) 1,75x1,55x
Free Cash Flow1 4 4375 224
ROE (Net Profit / Equities) 38,2%42,1%
Shareholders' equity1 11 47215 071
ROA (Net Profit / Asset) 5,50%6,41%
Assets1 79 76898 828
Book Value Per Share2 3,763,07
Cash Flow per Share2 1,961,58
Capex1 1 1721 129
Capex / Sales 3,44%3,88%
Announcement Date 02/09/2022-
Previous period Next period
1 GBP in Million
2 GBP
Estimates
Financial Ratios
Size 2022e 2023e
Capitalization 58 089 M GBP -
Enterprise Value (EV) 72 438 M GBP 71 978 M GBP
Valuation 2022e 2023e
P/E ratio (Price / EPS) 8,67x 10,8x
Capitalization / Revenue 2,00x 2,01x
EV / Revenue 2,49x 2,50x
EV / EBITDA 7,83x 7,36x
Yield (DPS / Price) 4,23% 3,88%
Price to book (Price / BVPS) 4,69x 3,93x
Profitability 2022e 2023e
Operating Margin (EBIT / Sales) 27,3% 29,3%
Operating Leverage (Delta EBIT / Delta Sales) -0,66x -
Net Margin (Net Profit / Revenue) 21,8% 18,3%
ROA (Net Profit / Asset) 6,41% 9,03%
ROE (Net Profit / Equities) 42,1% 44,7%
Rate of Dividend 36,7% 41,9%
Balance Sheet Analysis 2022e 2023e
CAPEX / Sales   3,88% 4,15%
Cash Flow / CA 21,9% 23,7%
Capital Intensity (Assets / Revenue) 3,40x 2,02x
Financial Leverage (Net Debt / EBITDA) 1,55x 1,41x
Price Earning Ratio
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS & Dividend